The FDA-centric Australian CRO championing innovative US and global biotech firms. 

Delivering high quality clinical research at a fraction of the cost.

Recently featured in

Why do so many US and global biotech firms bring their early-stage clinical trials to Australia?

home page icons_govt grant access icon
Government Grant Access

43.5% Government R&D tax incentive (even for foreign companies)

home page icons_fast quality research icon
Fast, High-Quality Research

Fast start-up time without sacrificing quality – 8-12 weeks on average (no IND required)

home page icons_regulatory expertise icon
FDA Regulatory Expertise

iNGENū's in-house regulatory team specializes in US FDA Pre-INDs and IND submissions

home page icons_therapeutic leaders icon
Diverse Therapeutic Specialty Leaders

Our team comprises physician and scientific specialists in a wide variety of areas


Our trusted partners

Our Mission

Our core mission is to create access to high quality clinical research globally by removing financial and other unnecessary barriers.


"We have been using iNGENū for a Phase 1, first-in-human trial of our investigational drug. We have used iNGENū for: Medical writing, project management, clinical data management and full end-to-end, clinical trial execution and monitoring.
We have been very happy with all aspects of the management of the clinical trial and have been particularly impressed by the out-of-the-box creative solutions to speed up and reduce overheads for our company during this clinical trial."

Giles Moss
Chief Executive Officer

iNGENu testimonial-logos-monotone-1

Meet our Clinical
Leadership Team